Congenital diseases reveal a lot about human biology

México Noticias Noticias

Congenital diseases reveal a lot about human biology
México Últimas Noticias,México Titulares
  • 📰 TheEconomist
  • ⏱ Reading Time:
  • 67 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 92%

The process of trying to establish the cause of a rare disease can drag on for five years. Genetic testing can cut this '“diagnostic odyssey” down to weeks

showed Dr Nizar’s sons a pain chart, they asked her what the smiley face at one end of the scale meant. The boys do not know, Dr Nizar says, what it is like to live without pain. Not all the diseases caused by calamitously failed single genes are quite that awful. But unlike the more generalised genomic influences on health—those to which everyone is heir, but few know about—people with serious congenital diseases have no escape or respite; their symptoms are inescapable.

Sometimes the correct care has dramatic results. Jessica was four years old when sequencing showed that the disease affecting her movement and development stemmed from a misprint in a gene called. This meant her cells did not make enough of a protein that transports sugar into the brain, thus leaving it chronically underpowered. Giving Jessica a carefully tailored low-carbohydrate diet activated an alternative way of getting calories to herbrain.

Similarly, studies of a Chinese family with a rare form of erythromelalgia, which causes burning pain and redness in the feet, are driving the development of new painkillers. Studies of the faultygene found in families with a genetic disorder that gives them poor coronary health inspired a whole class of new anti-cholesterol drugs that are more effective than statins.

Many hope that various new technologies could drastically reduce the costs of bespoke treatments for at least some congenital diseases. Most drugs today work by targeting a protein—either one of the body’s proteins that is misbehaving, or a protein in a pathogen that is achieving its goals all too well. The drug has to be tailored to the shape and activity of the protein it targets, while not messing up the workings of other inoffensive proteins that are doing vital work. That isn’t easy.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

TheEconomist /  🏆 6. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Anxious About Coronavirus? Lizzo Has a Soothing Meditation Just for YouAnxious About Coronavirus? Lizzo Has a Soothing Meditation Just for You“There’s the disease and then there’s the fear of the disease,” musician offered during 30-minute session
Leer más »

'Complete saturation': Italian hospital is receiving a new coronavirus patient every 5 minutes'Complete saturation': Italian hospital is receiving a new coronavirus patient every 5 minutesA top infectious disease expert cautioned Thursday that the country is likely two weeks away from seeing the deadly disease reach its peak.
Leer más »

U.S. Cases of Coronavirus: Here's an Updated Map of the SpreadU.S. Cases of Coronavirus: Here's an Updated Map of the SpreadCoronavirus originated in Wuhan, China, in late December and has quickly spread worldwide, including throughout the United States.
Leer más »

What Ebola taught Dallas about fear in the age of coronavirusWhat Ebola taught Dallas about fear in the age of coronavirusCombating an outbreak, whether Ebola or coronavirus, is about fighting more than just disease
Leer más »

U.S. CDC reports 1,678 coronavirus cases, death tally of 41U.S. CDC reports 1,678 coronavirus cases, death tally of 41The U.S. Centers for Disease Control and Prevention (CDC) on Friday reported 1,6...
Leer más »



Render Time: 2025-04-15 07:04:22